Back

PREPARE-IT: Icosapent Ethyl Versus Placebo in People Exposed to COVID-19

29 August 2021 (08:33 - 08:45)
Organised by:
Congress Presentation Part of: Late Breaking Trials - COVID-19 Public Health ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Rafael Diaz

Estudios Cardiologicos Latinoamerica (ECLA), Rosario (Argentina)

3 More presentations in this session

Presentation thumbnail
Colchicine in Patients Hospitalized with COVID-19
Doctor R. Diaz (Rosario, AR)
Slides Video
Presentation thumbnail
The Michelle trial: Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy
Doctor E. Ramacciotti (Santo Andre, BR)
Slides Video
Presentation thumbnail
Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial
Doctor M. Zile (Charleston, US)
Slides Video

Access the full session

Session thumbnail
Late Breaking Trials - COVID-19
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Cost-effectiveness of HerzMobil Tirol, a multidimensional post-discharge disease management program for heart failure patients Economic evaluation along a one-year observation period
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Presentation
Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources